Cell sensitivity to reaferon in patients with renal cell cancer after reaferon therapy

  • E. A. Shkapova
  • L. M. Kurtasova
  • A. A. Savchenko
Article
Received:
  • 28 Downloads

Abstract

Individual sensitivity of blood neutrophils to IFN-α2a was studied in vitro in patients with renal cell cancer before and after the first course of reaferon therapy. Cell sensitivity changed after reaferon therapy in 85% patients. This necessitates evaluation of individual cell sensitivity not only before therapy, but also before the next course of therapy.

Key Words

interferon renal cell cancer neutrophils chemiluminescence 
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    D. N. Mayanskii and I. G. Ursov, Lectures in Clinical Pathology [in Russian], Novosibirsk (1997).Google Scholar
  2. 2.
    J. Kirkwood, Semin. Oncol., 29, No. 3, Suppl. 7, 18–26 (2002).PubMedCrossRefGoogle Scholar
  3. 3.
    D. Nests, Interferons. Biological Activities and Clinical Efficacy, Berlin (1997), pp. 12–16.Google Scholar
  4. 4.
    G. Uze, G. Lutfalla, and K. E. Mgenesen, J. Interferon Cytokine Res., 15, No. 1, 3–26 (1995).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2007

Authors and Affiliations

  • E. A. Shkapova
    • 1
  • L. M. Kurtasova
    • 1
  • A. A. Savchenko
    • 2
  1. 1.Krasnoyarsk Territorial Oncological CenterRussia
  2. 2.Institute of Medical Problems of the NorthSiberian Division of Russian Academy of Medical SciencesKrasnoyarsk

Personalised recommendations